Literature DB >> 22245121

Hepatocellular hypertrophy and cell proliferation in Sprague-Dawley rats from dietary exposure to potassium perfluorooctanesulfonate results from increased expression of xenosensor nuclear receptors PPARα and CAR/PXR.

Clifford R Elcombe1, Barbara M Elcombe2, John R Foster3, Shu-Ching Chang4, David J Ehresman5, John L Butenhoff6.   

Abstract

The present study investigated the potential role for activation of PPARα and CAR/PXR by potassium PFOS (K⁺ PFOS) with respect to the etiology of hepatic hypertrophy and hepatocellular adenoma in rats. Male Sprague-Dawley rats were fed K⁺ PFOS (20 or 100 ppm) for either 1, 7, or 28 days. Wyeth 14,643 (Wy 14,643, 50 ppm) and phenobarbital (PB, 500 ppm) were the controls for PPARα and CAR/PXR activation, respectively. Measurements included: plasma ALT, AST, cholesterol, triglycerides, and glucose; liver protein and DNA content; liver activities of palmitoyl CoA oxidase (ACOX), Cyp4A, CYP2B, and CYP3A; induction of liver CYP4A1, CYP2E1, CYP2B1/2, and CYP3A1 proteins (SDS-PAGE and Western blots); liver and thyroid microscopic histopathology, apoptotic index, and cell proliferation index. Terminal body weight was decreased by K⁺ PFOS (100 ppm) and Wy 14,643. All test-compound treatments increased liver weight. Plasma lipids were decreased by both PFOS and Wy 14,643. After treatment for 1 day, K⁺ PFOS (100 ppm), PB, and Wy 14,643 increased mean hepatic DNA concentration and total hepatic DNA, and total DNA remained elevated after treatment for 7 days and 28 days (PB and Wy 14,643 only). Hepatic P450 concentration was elevated after 7 and 28 days by K⁺ PFOS and by PB. K⁺ PFOS and Wy 14,643 increased liver activities of ACOX and CYP4A as well as increased liver CYP4A1 protein. By 28 days of treatment, K⁺ PFOS and PB increased liver activities of CYP2B and CYP3A as well as increased liver CYP2B1/2 and CYP3A1 proteins, and Wy 14,643 increased CYP2B enzyme activity to a slight extent. All test compounds increased the liver cell proliferative index and decreased the liver apoptotic index. No histological changes of the thyroid were noted; however, PB and WY increased thyroid follicular cell proliferation index (seven-day treatment only), while K⁺ PFOS did not. The thyroid follicular cell apoptotic index did not differ between groups. The hepatomegaly and hepatocellular adenoma observed after dietary exposure of Sprague-Dawley rats to K⁺ PFOS likely are due to the increased expression of xenosensor nuclear receptors PPARα and CAR/PXR. Given the markedly lower or absent response of human hepatocytes to the proliferative stimulus from activation of PPARα and CAR/PXR, the hepatocellular proliferative response from activation of these receptors by PFOS observed in rats is not expected to be of human relevance.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245121     DOI: 10.1016/j.tox.2011.12.014

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  24 in total

Review 1.  Pregnane xenobiotic receptor in cancer pathogenesis and therapeutic response.

Authors:  Satyanarayana R Pondugula; Sridhar Mani
Journal:  Cancer Lett       Date:  2012-08-29       Impact factor: 8.679

2.  Perfluorooctane sulfonate alters gut microbiota-host metabolic homeostasis in mice.

Authors:  Limin Zhang; Bipin Rimal; Robert G Nichols; Yuan Tian; Philip B Smith; Emmanuel Hatzakis; Shu-Ching Chang; John L Butenhoff; Jeffrey M Peters; Andrew D Patterson
Journal:  Toxicology       Date:  2020-01-08       Impact factor: 4.221

3.  Paradoxical Protective Effect of Perfluorooctanesulfonic Acid Against High-Fat Diet-Induced Hepatic Steatosis in Mice.

Authors:  Ian Huck; Kevin Beggs; Udayan Apte
Journal:  Int J Toxicol       Date:  2018-08-22       Impact factor: 2.032

Review 4.  Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis.

Authors:  Zhiwei Hu; Samira A Brooks; Valérian Dormoy; Chia-Wen Hsu; Hsue-Yin Hsu; Liang-Tzung Lin; Thierry Massfelder; W Kimryn Rathmell; Menghang Xia; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Dustin G Brown; Kalan R Prudhomme; Annamaria Colacci; Roslida A Hamid; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Leroy Lowe; Lasse Jensen; William H Bisson; Nicole Kleinstreuer
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

5.  The role of hepatocyte nuclear factor 4-alpha in perfluorooctanoic acid- and perfluorooctanesulfonic acid-induced hepatocellular dysfunction.

Authors:  Kevin M Beggs; Steven R McGreal; Alex McCarthy; Sumedha Gunewardena; Jed N Lampe; Christoper Lau; Udayan Apte
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-03       Impact factor: 4.219

6.  Effects of perfluorooctanesulfonate and perfluorobutanesulfonate on the growth and sexual development of Xenopus laevis.

Authors:  Qin-Qin Lou; Yin-Feng Zhang; Zhen Zhou; Ya-Li Shi; Ya-Nan Ge; Dong-Kai Ren; Hai-Ming Xu; Ya-Xian Zhao; Wu-Ji Wei; Zhan-Fen Qin
Journal:  Ecotoxicology       Date:  2013-08-02       Impact factor: 2.823

7.  PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.

Authors:  Mitchell B Rosen; Kaberi P Das; John Rooney; Barbara Abbott; Christopher Lau; J Christopher Corton
Journal:  Toxicology       Date:  2017-05-27       Impact factor: 4.221

Review 8.  Thyroid disruption by perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA).

Authors:  F Coperchini; O Awwad; M Rotondi; F Santini; M Imbriani; L Chiovato
Journal:  J Endocrinol Invest       Date:  2016-11-11       Impact factor: 4.256

Review 9.  The Roles of Xenobiotic Receptors: Beyond Chemical Disposition.

Authors:  Bryan Mackowiak; Jessica Hodge; Sydney Stern; Hongbing Wang
Journal:  Drug Metab Dispos       Date:  2018-05-14       Impact factor: 3.922

10.  Pregnane X Receptor and Cancer: Context-Specificity is Key.

Authors:  Satyanarayana R Pondugula; Petr Pavek; Sridhar Mani
Journal:  Nucl Receptor Res       Date:  2016-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.